Tevogen CEO invests $500,000 in new headquarters in Warren, NJ for AI platform development

From GlobeNewswire: 2025-06-30 14:28:00

Tevogen’s CEO, Dr. Ryan Saadi, has contributed $500,000 towards building a new corporate headquarters in Warren, NJ. The new facility will centralize cross-functional teams and support the Tevogen.AI initiative, focusing on AI platforms to improve cell therapies. This investment demonstrates leadership’s commitment to the company’s long-term vision of accessible and affordable treatments. Forward-looking statements highlight Tevogen’s plans for growth and development, emphasizing the need for additional capital and potential risks in the healthcare industry. The CEO’s contribution underscores Tevogen’s dedication to innovation and patient access to cutting-edge therapies. Contact Tevogen Bio Communications for more information.



Read more at GlobeNewswire: Tevogen CEO Contributes to Build-Out and First-Year